Evidence map›Paper›PMID 39592434›Full record

ArticleThe European journal of neuroscience2024

Exploring neurofeedback as a therapeutic intervention for subjective cognitive decline.

Véronique Paban, Lewis Feraud, Arnaud Weills, Fabien Duplan

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Véronique PabanCNRS-UMR 7077, CRPN, Aix Marseille Univ, Marseille, France.ORCID 0000-0001-7758-3302
Lewis FeraudCNRS-UMR 7077, CRPN, Aix Marseille Univ, Marseille, France.
Arnaud WeillsCNRS-UMR 7077, CRPN, Aix Marseille Univ, Marseille, France.
Fabien DuplanPsychomotricien, Aix-en-Provence, France.

Funding

Janssen Horizon 214535, UMR7077
6 · The paper itself

Abstract

impact statementThis study addresses the pressing issue of subjective cognitive decline in aging populations by investigating neurofeedback (NFB) as a potential early therapeutic intervention. By evaluating the efficacy of individualised NFB training compared to standard protocols, tailored to each participant's EEG profile, it provides novel insights into personalised treatment approaches. The incorporation of innovative elements and rigorous analytical techniques contributes to advancing our understanding of NFB's modulatory effects on EEG frequencies and cognitive function in aging individuals. ABSTRACT: In the context of an aging population, concerns surrounding memory function become increasingly prevalent, particularly as individuals transition into middle age and beyond. This study investigated neurofeedback (NFB) as a potential early therapeutic intervention to address subjective cognitive decline (SCD) in aging populations. NFB, a biofeedback technique utilising a brain-computer interface, has demonstrated promise in the treatment of various neurological and psychological conditions. Here, we evaluated the efficacy of individualised NFB training, tailored to each participant's EEG profile, compared to a standard NFB training protocol aimed at increasing peak alpha frequency power, in enhancing cognitive function among individuals experiencing SCD. Our NFB protocol incorporated innovative elements, including the implementation of a criterion for learning success to ensure consistent achievement levels by the conclusion of the training sessions. Additionally, we introduced a non-learner group to account for individuals who do not demonstrate the expected proficiency in NFB regulation. Analysis of electroencephalographic (EEG) signals during NFB sessions, as well as before and after training, provides insights into the modulatory effects of NFB on EEG frequencies. Contrary to expectations, our rigorous analysis revealed that the ability of individuals with SCD to modulate EEG signal power and duration at specific frequencies was not exclusive to the intended frequency target. Furthermore, examination of EEG signals recorded using a high-density EEG showed no discernible alteration in signal power between pre- and post-NFB training sessions. Similarly, no significant effects were observed on questionnaire scores when comparing pre- and post-NFB training assessments.

Indexed as

Cognitive DysfunctionElectroencephalographyNeurofeedbackAgedFemaleHumansMaleMiddle Agedelectroencephalographymemory complaintsneurofeedbacksubjective cognitive decline

Identifiers

PMID39592434
PMCPMC11647435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.